Hi everyone,
I am planning to perform MD simulations on a GPCR that contains an unstructured ICL3 region (~70 amino acids). I would like to ask for advice regarding N- and C-terminal treatment in this context.
Any insights or references related to CHARMM force field conventions or best practices in GPCR modeling would be greatly appreciated.
Thank you!